Philips Azurion neuro biplane system
Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office
March 19, 2024 05:00 ET | Royal Philips
March 19, 2024   Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is one of the leading patent applicants at the...
nykode theraputics Logo RGB.png
Nykode Therapeutics Announces Advances in the Inverse Vaccine Platform With the Potential to Treat Autoimmune Diseases
March 19, 2024 02:00 ET | Nykode Therapeutics ASA
OSLO, Norway, March 19, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies,...
Obseva Logo highresolution.jpg
ObsEva Announces Update on Board of Directors
March 19, 2024 02:00 ET | ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 18, 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing and commercializing novel...
MAIN Hippocratic_Logo_Full_Color.jpg
Hippocratic AI Raises $53 Million Series A at a $500 Million Valuation
March 18, 2024 18:05 ET | Hippocratic AI
PALO ALTO, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Hippocratic AI, the company building the first safety-focused Large Language Model (LLM) for healthcare, today announced the close of a $53...
MAIN Hippocratic_Logo_Full_Color.jpg
Hippocratic AI Announces Collaboration with NVIDIA to Develop Super-Low-Latency “Empathy Inference” for One of the World’s First Generative AI-Powered Healthcare Agents
March 18, 2024 18:05 ET | Hippocratic AI
PALO ALTO, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Today, Hippocratic AI announced a collaboration with NVIDIA to develop empathetic AI healthcare agents — powered by the NVIDIA AI platform –...
NVIDIA Healthcare Microservices
NVIDIA Healthcare Launches Generative AI Microservices to Advance Drug Discovery, MedTech and Digital Health
March 18, 2024 17:16 ET | NVIDIA
SAN JOSE, Calif.—GTC, March 18, 2024 (GLOBE NEWSWIRE) -- NVIDIA today launched more than two dozen new microservices that allow healthcare enterprises worldwide to take advantage of the latest...
ASSUME THAT I CAN - World Down Syndrome Day 2024
Global Down Syndrome Foundation is Proud to Support Cheeky Awareness Video “Assume That I Can” Taking the Internet by Storm
March 18, 2024 17:00 ET | Global Down Syndrome Foundation
Denver, CO, March 18, 2024 (GLOBE NEWSWIRE) -- The Global Down Syndrome Foundation (GLOBAL) is proud to support the international awareness campaign video, “Assume That I Can,” that is taking the...
OBI Logo.jpg
OBI Pharma annonce des présentations par affiches à la réunion annuelle de l’AACR 2024 pour OBI-992 et la plateforme CAM GlycOBI™
March 18, 2024 16:22 ET | OBI Pharma Inc.
TAIPEI, Taïwan, 18 mars 2024 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx : 4174) a annoncé aujourd’hui des données précliniques portant sur OBI-992, un conjugué anticorps-médicament (« CAM »)...
OBI Logo.jpg
OBI Pharma kündigt Posterpräsentationen zu OBI-992 und zur GlycOBI™-AWK-Plattform auf der AACR-Jahrestagung 2024 an
March 18, 2024 16:22 ET | OBI Pharma Inc.
TAIPEI, Taiwan, March 18, 2024 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174) hat heute präklinische Daten zu OBI-992 bekanntgegeben, einem potenziell in seiner Klasse führenden...
Annexon_Logo_RGB.png
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
March 18, 2024 16:05 ET | Annexon Biosciences
BRISBANE, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living...